Document is current
Any future updates will be listed below
-
Authors
Takayoshi, Tomofumi
Hirota, Yushi https://orcid.org/0000-0002-3035-4155
Yamamoto, Akane
Yoshimura, Kai
Nishikage, Seiji
Ueda, Mariko
Ogawa, Wataru
- License Information
-
More Information
Article History
Received: 26 August 2024
Accepted: 18 December 2024
First Online: 3 February 2025
Declarations
:
: Yushi Hirota has received lecture fees from Eli Lilly Japan K.K., Sanofi Aventis, Abbott Japan, Terumo Co., and Sumitomo Pharma Co. Ltd.; research funding from Sumitomo Pharma Co. Ltd., Medtronic Japan Co. Ltd., and Kyowa Kirin Co. Ltd.; and a donation from Abbott Japan. Wataru Ogawa has received lecture fees from Sumitomo Pharma Co. Ltd., Nippon Boehringer Ingelheim Co. Ltd., Abbott Japan, and Novo Nordisk Pharma Ltd.; research grants from Noster Inc., Nippon Boehringer Ingelheim Co. Ltd., Eli Lilly Japan K.K., Abbott Diabetes Care UK Ltd., Sumitomo Pharma Co. Ltd., and Teijin Pharma Ltd.; and donations from Kowa Co. Ltd., Novo Nordisk Pharma Ltd., Sumitomo Pharma Co. Ltd., Takeda Pharmaceutical Co. Ltd., and Teijin Pharma Ltd. All remaining authors declare that they have no conflict of interest.
: The ethics committee of Kobe University Graduate School of Medicine.
: Informed consent was obtained in the form of an opt-out on the hospital.
: Not applicable.
